Study of Serum Adeosine Deaminase Levels in FNAC Confirmed Cases of Tuberculous Lymphadenitis in South Karnataka Population – Retrospective Study
International Journal of Current Pharmaceutical Review and Research · 16.03.2026 · 18 (03)
DOI: 10.25258/ijcpr.18.3.79 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 16.03.2026. Verfasst von Jaya Kumar CK und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Tuberculosis is quite a common disease in underdeveloped countries like India. Hence, FNAC is an easy diagnostic tool to confirm tuberculous lymphadenitis and to determine sensitivity and specificity.
Method
70 adults diagnosed with tuberculous lymphadenitis by FNAC, followed by measurement of elevated serum adenosine deaminase levels, were recorded.
Results
Out of 70 patients, 80% had granulomatous lymphadenitis and 20% had granulomas/20 HPE. The adenosine deaminase levels ranged between 31 to 40 I1/L.
Conclusion
The FNAC study of adenosine deaminase elevation is a confirmation of tuberculosis in the suspected enlargement of lymph nodes.
Zitieren
APA
CK, J. K., GV, N., & M, M. K. (2026). Study of Serum Adeosine Deaminase Levels in FNAC Confirmed Cases of Tuberculous Lymphadenitis in South Karnataka Population – Retrospective Study. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.79
Vancouver
CK JK, GV N, M MK. Study of Serum Adeosine Deaminase Levels in FNAC Confirmed Cases of Tuberculous Lymphadenitis in South Karnataka Population – Retrospective Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.79
BibTeX
@article{CK2026,
author = {CK, Jaya Kumar and GV, Nandini and M, Manoj Kumar},
title = {Study of Serum Adeosine Deaminase Levels in FNAC Confirmed Cases of Tuberculous Lymphadenitis in South Karnataka Population – Retrospective Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {03},
doi = {10.25258/ijcpr.18.3.79}
}
EUVIMED